Fingerprint
Dive into the research topics of 'Data from the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trial: Implications for Use of Aromatase Inhibitors in 2003'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Data from the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trial: Implications for Use of Aromatase Inhibitors in 2003
Aman U. Buzdar, James Ingle, Myles Brown, Steven Come, Richard Santen
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations